Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T23:13:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T23:22:22.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The History page now shows Revision: v3.7.0, replacing the prior v3.6.6. This indicates a metadata or template update to how the record history is displayed, not a change to the study data.
    Difference
    0.1%
    Check dated 2026-09-20T22:34:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new version adds major sections to the record, including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Description, and Study Status, expanding the publicly visible content of the trial history. Additionally, the entry dated 2026-08-18 was removed.
    Difference
    0.5%
    Check dated 2026-09-13T21:49:01.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.6.6 added, indicating an update to the record's revision version (replacing v3.6.5). This reflects an administrative change to the record's history rather than any change to study data or content.
    Difference
    0.1%
    Check dated 2026-08-30T21:53:23.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new history entry on 2026-07-24 adds a Terminated status with a Business Reason and updates Study/Recruitment Status. The prior Completed entry from 2025-10-15 is removed.
    Difference
    0.4%
    Check dated 2026-08-23T18:57:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.